Thank you for joining us
today. Industry Innovations Webinars are archived on the ATS YouTube channel
under the Industry Innovation playlist.
Expect a brief satisfaction survey via email in the next few days. Your feedback is appreciated as it helps improve programming for the future.
Despite multiple treatment
options, patients with PAH still face a devastating and progressive
disease. This program will focus on the imbalances in BMPR2 and activin
receptor signaling that may drive PAH progression. A new therapeutic
approach that aims to rebalance this signaling will be discussed in the context
of potential disease modification.
Disclaimer: Opinions expressed, and resources shared may not have been reviewed by the ATS prior to distribution through ATS channels, or reflect official positions of the ATS, unless it is explicitly noted as a result of official ATS approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the ATS unless it is explicitly noted as a result of official ATS approval.
Webinar is sponsored by Acceleron. By registering for this webinar, you understand your information will be shared with the sponsor.
No CEU's or credits are provided for this webinar.